Professional Documents
Culture Documents
sprasad@rcsed.ac.uk
098 30 50 7754
UK Training
Dorchester Rick Powell 1994
Swindon Paul McCormack 1995
Oxford 1996 Paul Rosen & Hung Cheng
Wirral Russell P Phillips -1997-1999
Sheffield Prof Ian Rennie, John Talbot,
James West 2000-2001
MS Kolkata 1993
FRCS Edinburgh 1994
CCST - 2001
FRCOphth (London) 2006
FACS American College of Surgeons 2008
AAO Achievement Award 2008
AAO International Education Award 2009
ASCRS Film Festival Award 2010
ASRS Honors Award 2013
DIABETIC VITRECTOMY
What do I do?
Medical Retina
Vitreo-retinal surgery
Cataract surgery
Premium IOLs
Toric IOLs
Multifocal IOLs
Diabetes
1550 BC - Ebers Papyrus of ancient
Egypt
too great emptying of urine
the river Nile between the thighs
Remedies recommended
diet of wheat grains, grapes, honey
and berries
Papyrus discovered - Luxor 1872
George Maurice Ebers
Diabetes
17.1 crores worldwide
India 2000 3.17 crores
36.6 crores in 2030
Maximum increase in India
7.94 crores India
4.23 crores China
Vital Function %
100
Good
Bad
0
Failure
25
50
75
100
India
One Ophthalmologist / 1 lakh
population
UK 2.3 Ophthalmologists / 1 lakh
population
Preproliferative
Maculopathy
Proliferative
Advanced Diabetic Eye Disease
The commonest cause of decreased visual acuity due to
diabetic retinopathy is maculopathy
Examination
Slit lamp
External exam
Pressure measurements
Fundus examination
Retinal Examination
Direct Ophthalmoscope
small field
2 D view
Uniocular
11 November 1998
Retinal Examination
Fundus photography
Large field
Can be done by technician
Diabetic maculopathy
Diabetic maculopathy
12% of treated eyes developed
moderate visual loss in spite of
treatment
Less than 3% of treated eyes
improved VA significantly (15
ETDRS letters)
d
5
s
y
a
Post 6/9
Case 2
Pre RE 6/36
Pre LE 6/60
Post RE 6/9
Post LE 6/12
Steroids
Triamcinolone
Pseudophakic eyes
Resistant cases
Dexamethasone
Ozurdex
Fluocinolone Acetonide
Iluvien, Retisert
Figure 5
Ranibizumab
9 RCTS in DME
READ-2
REVEAL
RESOLVE
RESTORE
RISE & RIDE
DRCRN trial
2 years 10 letters gain in BCVA
No difference between
Ranibizumab + prompt laser (deferred laser
worse)
Laser alone
Bevacizumab
8 RCTS in DME
BOLT Avastin vs Laser
N=80, two years
iVB +8.6 letters
Laser -0.5 letters
Key points
Laser therapy = standard of care
non-center-involving oedema
DME without decreased VA
Ranibizumab injections
monthly for 3 visits,
then as needed depending on VA (with
or without OCT) stability
somduttprasad@gmail.com 09830507754